Share on StockTwits
 

Albany Molecular Research (NASDAQ:AMRI) released its earnings data on Wednesday. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.05, American Banking and Market News reports.

Shares of Albany Molecular Research (NASDAQ:AMRI) traded up 4.05% during mid-day trading on Wednesday, hitting $11.55. 166,465 shares of the company’s stock traded hands. Albany Molecular Research has a 52-week low of $6.61 and a 52-week high of $14.37. The stock’s 50-day moving average is $10.65 and its 200-day moving average is $11.76. The company has a market cap of $359.0 million and a price-to-earnings ratio of 33.74.

On a related note, analysts at Sterne Agee downgraded shares of Albany Molecular Research from a “buy” rating to a “neutral” rating in a research note on Tuesday, December 3rd. They now have a $12.00 price target on the stock, down previously from $15.00.

Albany Molecular Research, Inc (NASDAQ:AMRI) provides scientific services, technologies and products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.